Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| But otherwise, from a buyer's perspective, we're feeling pretty good |
| We continue to leverage sales development representatives to improve our client acquisition cost with higher lead to sales conversions on a more favorable cost base |
| This quarter was a testament to the strength of our business and the investments we've made to position the company for future growth |
| We're living our mission as the partner and trusted advisor to the practices we serve, which creates strong retention, the right to cross sell solutions and net new client wins |
| In collaboration with our NextGen Insights team, we're actively pursuing new and expanded agreements with health data partners which will drive future revenue growth at an attractive margin |
| And the beauty of our recurring business model is 91%, like we have really good visibility |
| You'll see improvements on the gross margin as those -- really good people are redeployed to other parts of our business, hopefully, into more billable roles going forward, but that'll gradually go down and we're excited to keep all that great talent that we've built up here going forward |
| But we need better than $39 million in Q2 and we're -- the current forecast looks better than that |
| As we were the first and remain a leader in this transition, we believe that positions us well to further accelerate Surround Solution adoption and scale |
| Our existing clients continue to adopt our Surround solutions, which helps them optimize their financial performance and clinical outcomes, resulting in a clear return on investment, and high growth across our diverse recurring revenue streams |
| We saw strong momentum in patient volumes, which led to higher demand in the quarter than originally planned in our transaction and data revenue line, specifically our Patient Pay offering |
| We feel good still about the year |
| So our pipeline looks good for this quarter, looks good for the year, looks good for continued growth, little up and down |
| We've made good progress over the quarter in advancing all these initiatives |
| So it was a good quarter from a sales perspective -- from a SaaS -- especially from a SaaS perspective |
| Our overall positive outlook reflects the tailwinds we created by solely focusing on ambulatory care, our resilient business model and our focus on driving shareholder value |
| As noted in the press release, we are raising the bottom end of our revenue range based on the solid start to the year |
| Professional services revenue of $9.9 million grew 34% as we continue to work down the backlog to bring new customers live, and there was also a benefit from closing fixed fee contracts, which resulted in a onetime uplift |
| I’m also excited for the opportunity we've seen in our operability, specifically in supporting global clients who also have scaled needs |
| The growth was fueled by a combination of revenue from the acquisition of TSI, plus the acceleration of organic solutions |
| And finally, touching on value based care, we have been partnering with clients seeking to achieve superior quality and financial outcomes when participating in ACOs and other alternative payment models |
| We believe the ability to deliver insights at the point of care through the provider's current system of use remains a differentiating capability for enabling providers to take on risk |
| Transaction and Data Services revenue of $37.6 million grew 38% and managed services revenue of $34.8 million grew 13% |
| These providers are using NextGen's leading population health analytics solutions and wraparound services to improve care quality and generate significant savings |
| I'm pleased to report solid top and bottom line results to start the new fiscal year |
| We see opportunity to further optimize our operating model, ensuring we have the right capabilities in place to deliver growth at scale for years to come |
| Building on the momentum created during fiscal 2023, company executed across all fronts and is well positioned to deliver double digit revenue growth, create operating leverage and demonstrate effective capital management |
| What's exciting about the acquisition is, it further strengthens our position in the health data arena |
| We exceeded our first quarter sales targets and we're excited for the opportunity to get in front of even more clients as we plan to host over 200 attendees at our Leaders in Rheumatology Conference, where we will deepen our relationships with new and prospective clients and partners |
| When I think about the insights, the revenue that will be generated insights will be higher margin revenue and will help to lift the overall corporate margin |
| Statement |
|---|
| Gross margin of 44.8% was down approximately 300 basis points compared to the same quarter last year |
| We tried to share that for next quarter we're expecting it to be negative because of the cash payment |
| We expect free cash flow to be negative next quarter due to the DOJ settlement and then return to a more normalized cash flow conversion rate for the remainder of the year |
| So from the office, we did see some softness in the base |
| Software revenue of $5 million was down year-over-year and under the six quarter trend, but in line with the longer term trend and in line with our internal plan |
| So ironically, outside the base, we're getting new clients, no change, but in the base saw some softness |
| And so, obviously, that will be negative |
| SG&A of $48.2 million decreased by 2% compared to the same quarter last year |
| Free cash flow for the quarter was a negative $16.8 million and was impacted by payments for TSI customer financing sales arrangements, annual bonus and convertible debt interest payment |
| And I think that's mainly a problem on the lower ends |
| The headwinds between the two factors you talked about |
| Limited free cash flow for the entire year |
| Especially if the Fed continues to raise rates |
| This transition continues to lessen our exposure to the lumpiness that comes with perpetual software licenses, which we've modeled a ramp down aligned with what we saw in the first quarter |
| This is a 4% decrease compared to the same quarter last year, which included several onetime pull forward investments |
| So the combination of those two are probably about half of the gross margin headwind |
| You probably saw that we went down some in perpetual, which is expected |
| So we're not nervous about that |
| We expect the long term to kind of go down or trend down as we really are pushing SaaS to all new clients |
Please consider a small donation if you think this website provides you with relevant information